Nosocomial infections (NIs) now concern 5 to 15% of hospitalized patients and can lead to complications in 25 to 33% of those patients admitted to ICUs. The most common causes are pneumonia related to mechanical ventilation, intra-abdominal infections following trauma or surgery, and bacteremia derived from intravascular devices. This overview is targeted at ICU physicians to convince them that the principles of infection control in the ICU are based on simple concepts and that the application of preventive strategies should not be viewed as an administrative or constraining control of their activity but, rather, as basic measures that are easy to implement at the bedside. A detailed knowledge of the epidemiology, based on adequate surveillance methodologies, is necessary to understand the pathophysiology and the rationale of preventive strategies that have been demonstrated to be effective. The principles of general preventive measures such as the implementation of standard and isolation precautions, and the control of antibiotic use are reviewed. Specific practical measures, targeted at the practical prevention and control of ventilator-associated pneumonia, sinusitis, and bloodstream, urinary tract, and surgical site infections are detailed. Recent data strongly confirm that these strategies may only be effective over prolonged periods if they can be integrated into the behavior of all staff members who are involved in patient care. Accordingly, infection control measures are to be viewed as a priority and have to be integrated fully into the continuous process of improvement of the quality of care.
A
ccording to the Institute of Medicine 1 in Washington, DC, preventable adverse events in the United States, including hospital-acquired infections, are responsible for 44,000 to 98,000 deaths annually and represent a cost of $17 to $29 billion. As precise epidemiologic data about these events are sparse, this estimation was extrapolated from two studies only. [2] [3] [4] [5] This report has generated a considerable debate in the medical literature. 6 -9 Nevertheless, data 10 -12 have suggested that the likelihood of the occurrence of these events may increase by 6% for each day spent in the hospital, and they were found to be more frequent among patients in ICUs.
During the last decade, the growing emphasis on outpatient medical management has resulted in a marked reduction of beds in many health-care institutions, and this policy has been responsible for an increasing severity of illness among hospitalized patients. Data from the Centers for Disease Control and Prevention (CDC) National Nosocomial Infection Surveillance (NNIS) system show a 17% increase in the number of ICU beds at the 117 participating hospitals from 1988 through 1995, as compared with a slight decrease in the total bed capacity. 13 Although representing only 5 to 15% of hospital beds, ICUs accounted for 10 to 25% of health-care costs, corresponding to 1 to 2% of the gross national product of the United States. 14 Nosocomial infections (NIs) affect Ͼ 2 million persons annually in the United States and concern 5 to 35% of patients who are admitted to ICUs. 15 They are viewed as an inexorable tribute to pay to the more aggressive management of the population, characterized by the use of sophisticated technologies and invasive devices. The pathophysiology of NIs includes colonization of the host by potentially dangerous pathogens, such as microorganisms from exogenous or endogenous sources, including resistant strains such as methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant enterococci (VRE), azole-resistant Candida spp, and extended-spectrum ␤-lactamase (ESBL) Gram-negative pathogens. Ventilator-associated pneumonia, catheter-related bloodstream infections, surgical site infections (SSIs), and urinary catheter-related infections account for Ͼ 80% of NIs. 16, 17 The Study on the Efficacy of Nosocomial Infection Control 15, 18, 19 from the CDC has suggested that at least one third of NIs are preventable through infection control programs, which have been implemented in most centers during the last 2 decades. Risk factors are well-identified and have been the target of efficient preventive measures. This may explain why NI rates are now included in the criteria used for assessing the quality of patient care in many institutions. Control and prevention include general measures such as hand hygiene, isolation and restriction of antibiotic use, and more specific measures that have been demonstrated to be efficient in reducing particular types of NIs. 20 -26 Definitions NI schematically encompasses any infection that is neither present nor incubating on hospital admission. Precise definitions have been largely debated in the literature, but those proposed by the CDC in 1988 27, 28 have been validated and are now widely used. Minor adaptations are generally proposed for specific populations, but infections are considered to be hospital-acquired if they develop at least 48 h after hospital admission without proven prior incubation. If infections occur up to 3 days after hospital discharge or within 30 days of an operative procedure, they are attributed to the admitting hospital or ward, or to the surgical procedure, respectively (Table 1) . 24,25,29 -32 A specific terminology is used to describe the epidemiology of NIs. The prevalence of infected patients is defined as the number of patients with an active infection divided by the total number of patients who are present at the time of the survey. The prevalence of infection is the number of active infections divided by the total number of patients who are present at the time of the survey. The incidence of infected patients is defined as the number of patients who developed any infection divided by the total number of patients at risk who are hospitalized in the ward concerned during a determined period of time. Once infected, patients cannot be considered at risk of infection. The incidence of infection is defined as the number of infectious episodes divided by the total number of patients who were hospitalized in the concerned ward during a determined period of time. The incidence-density of infection/infected patients refers to the number of infectious episodes/infected patients per 1,000 patient-days at risk. The latter is the most appropriate way to express infection rates and to measure the impact of preventive strategies. However, this approach mandates the prospective surveillance of all patients who are at risk for NIs with individual records of events considered both in the numerator and the denominator. 33, 34 Epidemiology of NIs Epidemiologic data collected from surveillance activities are used to determine NI rates. Benchmarking then may be used to monitor their evolution and to detect any unusual variation that may be potentially suspect of outbreaks or high endemic rates of NI. Importantly, NI rates vary widely according to the type of ICU and the population served. They may also vary with the type of surveillance (Table 2) . 22, 24, [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] A prevalence of 20.6% was reported by Vincent et al 16 in the European Prevalence of Infection in Intensive Care study, which included 10,038 patients from 1,417 European ICUs in 1992. Pneumonia was the most common NI (46.9%), followed by lower respiratory tract infection other than pneumonia (17.8%), urinary tract infection (UTI) (17.6%), and laboratory-confirmed bloodstream infection (12%). 16 Importantly, NIs are easier to compare if they are presented as incidence densities related to device use (eg, endotracheal tube, central venous catheter [CVC] , or urinary catheter) [ Table  3 ]. 24,37,39,40,42,44,50 -58 An incidence of 9.2%, corresponding to an incidence density of 23.7 episodes per 1,000 patient-days, was reported for the 164,034 patients in 119 ICUs surveyed from 1986 through 1990 in the NNIS system. 59 Data collected from 112 medical ICUs between 1992 and 1997 indicated that NIs developed in 7.8% of hospitalized patients (14,177 of 181,993 patients), corresponding to an incidence density of 19.8 episodes per 1,000 patientdays. UTIs (31%) were the most common, with 95% occurring in catheterized patients. Pneumonia, which was ventilator-associated in 86% of cases, represented 27% of all NIs, and bloodstream infections represented 19% (laboratory-confirmed, 18 .2%, and clinical sepsis, 0.8%), of which 87% were found to be catheterrelated. 35 NI device-related rates (ie, catheter-related UTI, central venous catheter-related bloodstream infections, and ventilator-associated pneumonia) were 5.5, 4.0, and 7.1, respectively, episodes per 1,000 device-days for coronary ICUs, 6.4, 5.3, and 6.8, respectively, for medical ICUs, 4.8, 6.9, and 4.0, respectively, for pediatric ICUs, and 4.6, 5.1, and 12.5, respectively, for surgical ICUs. 48, 50 Comparable incidences of NIs have been reported in ICUs from other developed countries. 17, 42, 60, 61 Moreover, preliminary data from the NNIS system suggest that riskadjusted NI rates decreased over time for these three infections that are continuously monitored in ICUs. 50 
Impact of NIs
A significant correlation was found between the prevalence rate of ICU-acquired infection and mortality rate. In the European Prevalence of Infection in Intensive Care study, laboratory-proven bloodstream infection (odds ratio [ Pus or culture-positive fluid discharges from a closed incision; A surgeon opens a closed incision, unless it is culture-negative; Incision dehiscence unless culture results are negative; Abscess diagnosed postoperatively using imaging techniques; and Discharge of pus from beneath a drain Bloodstream infection ‡ Primary bloodstream infection refers to a bacteremia (or fungemia) for which there was no documented distal source and includes those infections resulting from an IV line or arterial line infection Clinical sepsis has one of the following clinical signs or symptoms with no other recognized cause:
fever (Ͼ 38°C); hypotension (systolic blood pressure Յ 90 mm Hg); or oliguria (Ͼ 20 mL/h); plus all of the following: blood culture not performed or no organism detected in blood; no apparent infection at another site; and the physician administers appropriate antimicrobial therapy for sepsis Lower respiratory tract infection Pneumonia: new or increased production of purulent sputum and/or a fever Ն 38°C with clinical signs (ie, rales, dullness to percussion) and/or chest radiograph showing new or progressive infiltrate, consolidation, cavitation, or pleural effusion not attributable to another disease Ventilator-associated pneumonia: new radiographic infiltrate for at least 48 h and at least two of the following: fever Ն 38.5°C or Ͻ 35.0°C; leukocytes Ͼ 10,000/L or Ͻ 3,500/L, purulent sputum, or isolation of pathogenic bacteria from lower respiratory tract § UTI Symptomatic infection: a positive result on urine culture (Ն 10 5 microorganism/mL) and one of the following clinical signs: fever Ն 38°C; urgency; frequency; dysuria; loin pain; loin/suprapubic tenderness Asymptomatic bacteriuria: urine culture of Ն 10 5 microorganisms/mL of no more than two species, in the presence or absence of a catheter, no fever present (Ն 36°C), urgency, frequency, dysuria, or loin/suprapubic tenderness *Modified definitions applied at the University of Geneva Hospitals. 24,25,29 -32 †The presence of an implant extends the period of time during which a SSI can occur from 30 d to 1 yr after the procedure, provided that the infection is related to the operative procedure and involves one of the designated sites. Secondary infection is considered if it follows a complication which results in the discharge of serum, hematoma, cerebrospinal fluid, urine, bile, pancreatic juice, gastric or intestinal contents from the wound, contaminated by microorganisms from within the patient or from the environment. ‡Catheter-related bloodstream infections are defined as the isolation of the same organism from a (semi)quantitative culture of the distal catheter segment and from the blood of a patient with clinical symptoms of infection and no other apparent source of infection. In the absence of catheter culture, defervescence after removal of an implicated catheter from a patient with bloodstream infection is considered indirect evidence of infection. §Sample may be obtained by simple tracheal aspirate or by blinded or noninvasive techniques such as BAL or protected-specimen brush. Bacterial count of Ն 10 5 microorganisms/mL with no more than two species is generally considered significant from a midstream urine specimen. A bacterial count of Ն 10 3 microorganisms/mL can be considered significant if obtained from a suprapubic puncture or in the presence of an antibiotic.
associated with an increased mortality rate. Additional independent predictors of death were an acute physiology and chronic health evaluation (APACHE) II score Ͼ 20 (OR, 15.6; 95% CI, 9.3 to 26), prolonged (Ն 21 days) ICU stay (OR, 2.52; 95% CI, 1.99 to 3.18), age Ͼ 60 years (OR for age 60 to 69 years, 1.7; 95% CI, 1.07 to 2.71; OR for age Ն 70 years, 2.08; 95% CI, 1.31 to 3.31), the presence of organ failure on hospital admission (OR, 1.68; 95% CI, 1.45 to 19.5), and cancer as comorbidity (OR, 1.48; 95% CI, 1.23 to 1.79). 16 The analysis of the impact of NIs on health care revealed that they are responsible for a significant increase in mortality, morbidity, length of hospital and ICU stay, and resource utilization in almost all of the groups of patients studied (Table 4) . 22, [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] This impact is determined by the attributable part of these parameters. Accordingly, the attributable mortality of NI is defined as the difference in the death rate of patients and noninfected patients in a series adjusted for the presence of other confounding factors. Several epidemiologic methods may be used to determine the mortality, or any other parameter of the impact of a NI. Direct estimation is a simple method in which an experienced clinician subjectively estimates whether the death of a patient is related to the NI or not. This technique systematically underestimates the attributable part of the mortality. The appropriateness of the evaluation protocol is another direct method that is used to estimate the prolongation of the length of hospital stay. Based on standardized criteria, the patient is evaluated daily to determine whether the stay in the hospital is related to the underlying disease and/or to the presence of an NI. Another method compares two groups of patients, one with a specified NI and one without a specified NI. Differences are expected to be attributable to the NI. However, this technique does not take into consideration potential confounding parameters that may exist between the two groups of patients. This effect can be attenuated by including factors potentially related to death in multivariate analysis. Nonetheless, these adjustments are generally insufficient and the attributable part is often overestimated. The so-called casecontrolled studies (ie, those called, more appropriately, historical cohort studies with matching on potential confounders) are considered to be the best way to determine the impact of NIs. Infected and noninfected patients are carefully matched for several confounding factors related to the parameter investigated (eg, age, severity of underlying disease, associated comorbidities, and time of exposure to risk factors). Biased evaluations of the impact are Bloodstream infections includes episodes of primary bacteremia (3.0/1,000 patient-days). ¶Patients hospitalized for severe infections over a 6-year period. #Data reported are insufficient to extract details on incidence-densities for each type of infection.
minimal with this methodologic approach, except when case and control patients are matched too closely using variables that predict or confound the outcome of interest. 65 Crude mortality rates are particularly high in critically ill patients, but the attributable mortality varies according to the type of infection. The differences reported between the studies may be related to some confusion between the associated and the attributable parts (Table 4 ). In addition, some methodological bias also may play a role. Insufficient matching criteria (eg, low case/control ratio or few and irrelevant matching parameters) may overestimate the impact, but overmatching abolishes differences between case patients and control subjects. Cost-effectiveness analysis is based on these data, which imply that the controversies in the recent literature regarding the attributable mortality of NIs concerns not only epidemiologists but, also, ICU physicians who have to select and implement preventive strategies. 65, 80 
Risk Factors
Independent risk factors for NIs have been identified in several studies (Table 5) . 16, 42, 56, 64, 81, 82 Among them, the severity of underlying illness assessed by scoring systems such as APACHE II/III or simplified acute physiologic score II are the most widely used. However, these scores were designed to predict mortality and are less consistent predictors of NIs. 61, 83 These general scores also may be of limited value in the field of sepsis. In a series 84 of 88 consecutive patients with septic shock, we found a low predictive value for APACHE II and simplified acute physiologic II scores. A prolonged length of stay, mechanical ventilation, and the use of vascular accesses also were identified. Apart from the overall risk factors for NIs, more specific risk factors have been delineated from numerous studies designed to identify those associated with specific infections.
Understaffing and overcrowding in ICUs have been reported [85] [86] [87] to increase the risk of human errors, iatrogenic complications, and even death. They have also played an important role in several outbreaks and are to be considered as potential risk factors for the acquisition of NIs. 88 -91 Fridkin et al 92 reported an outbreak of catheter-related bloodstream infections that apparently were associated with total parenteral nutrition in critically ill surgical patients. After adjustment for confounding parameters (ie, type of nutrition, mechanical ventilation, and duration of hospitalization), the patient-to-nurse ratio was found to be a major independent risk factor. As compared with a patient-to-nurse ratio of 1, the relative risks (RRs) were 3. . The outbreak was stopped after a decrease in workload, reinforcement of single-dose medication, and increased compliance with hand hygiene before IV line handling, which rose from 25% to 70%.
Pathophysiology of NIs
The colonization of the host by potentially pathogenic microorganisms is a prerequisite for the further development of most NIs and may occur from exogenous or endogenous sources. As a consequence of the severity of the underlying diseases with possibly impaired host defenses, and in the presence of risk factors, critically ill patients are particularly susceptible to a rapid colonization by endemic pathogens of the hospital flora.
The endemic transmission of exogenous staphylococci and other potential pathogens by the hands of health-care workers (HCWs) is well-documented. 91,94 -97 Goldmann et al 98 reported the presence of Gram-negative bacilli on the hands of 75% of neonatal ICU personnel. A report from the National 99 Importantly, the hands of HCWs are only transiently contaminated and, as discussed later, appropriate hand hygiene measures are sufficient to remove the organisms and to stop the transmission. Many NIs are believed to arise from the endogenous flora of the skin, oropharyngeal, or GI tracts due to treatments such as chemotherapy, corticosteroid therapy, or antibiotic therapy, and also by the use of invasive devices such as intravascular or urinary catheters and nasogastric or endotracheal tubes. This flora also is responsible for the majority of surgical wound infections.
Microbiology
A continuous shift toward more resistant strains of bacteria has been reported for several decades. Concern has focused on MRSA, VRE, ESBLs, fluoroquinolone-resistant Pseudomonas aeruginosa, and fluconazole-resistant Candida spp. 100, 101 These pathogens have become the leading causes of NIs, particularly in ICUs where most were found to have a certain specificity according to the type of ICU. 13, 102, 103 The predominant pathogens reported in the ICUs participating in the NNIS and in European countries are coagulase-negative staphylococci (CoNS), S aureus, P aeruginosa, entercococci, and Candida spp (Table 6 ). 16, 35, 37, 60, 104 The factors responsible for this evolution are not fully understood, but antibiotic pressure certainly plays a major role. 105 Studies 106 -110 have repetitively demonstrated that antibiotic exposure, particularly to cephalosporins, constitutes an independent risk factor for colonization and infection with both resistant Gram-positive cocci and Gram-negative bacilli in ICUs. This selective pressure was recently emphasized by Harbarth et al 111 in their elegant analysis of the impact of cephalosporin-based prophylaxis in a cohort of 2,641 consecutive patients who had been referred for heart surgery over a 5-year period. As compared to short-term prophylaxis, prolonged prophylaxis (ie, Ͼ 48 h) was not associated with a decreased risk of SSI but was clearly correlated with an increased risk of colonization with resistant microorganisms.
A further relationship between antibiotic resistance and antibiotic use in ICUs is strongly suggested for some pathogens by a prospective survey in 41 hospitals included in phase 2 of the Intensive Care Antimicrobial Resistance Epidemiology project. 103 Average antimicrobial use, which was expressed as the daily defined dose per 1,000 patient-days, revealed that first-generation and thirdgeneration cephalosporins and parenteral vancomycin were the most commonly used agents in the ICUs included in the project. The demographics of these hospitals were similar to the 221 other institutions participating in the NNIS system, and susceptibility could be analyzed for 290,045 isolates collected over a 12-month period. The highest resistance rates occurred among isolates from ICU patients, followed in decreasing order by those from non-ICU patients and outpatients. These organisms included the following: methicillin-resistant CoNS (resistance rates, 75%, 60.4%, and 44.5%, respectively); MRSA (resistance rates, 35.2%, 31.9%, and 17.7%, respectively); VRE (resistance rates, 13.0%, 11.8%, and 2.5%, respectively); piperacillin-resistant P aeruginosa (resistance rates, 12.2%, 8.3%, and Device utilization ratio ϭ (95% catheter-days ϩ urinary-catheterdays ϩ mechanical ventilation-days)/length of stay.
6.0%, respectively); and ceftazidime-resistant, cefotaxime-resistant, or ceftriaxone-resistant Enterobacter spp (resistance rates, 25.0%, 22.3%, and 10.1%, respectively). All these stepwise decreases were statistically significant. In contrast, this was not the case for penicillin-resistant pnemococci (resistance rates, 9.5%, 10.4%, and 9.8%, respectively) or for fluoroquinolone-resistant P aeruginosa (resistance rates, 16.4%, 17.6%, and 20.0%). Apart from fluoroquinolones, which may have a similar exposure in both parts of the hospital, for each of the antimicrobial groups used at higher levels in ICUs there was a correspondingly higher rate of resistant pathogens among isolates from the ICU compared with non-ICU patients. Several reports 112 also have demonstrated the spread of antibiotic resistance from ICUs to other hospital wards.
S aureus and CoNS
Currently, Ͼ 60% of CoNS isolates and nearly 20% of S aureus isolates from ICUs are resistant not only to methicillin, but also to several other agents such as aminoglycosides, tetracyclines, and quinolones. 103, [113] [114] [115] Although not associated with higher mortality rates, compared with infections due to methicillin-sensitive S aureus, bacteremia due to MRSA may be more difficult to treat. 30 The proportion of cases in which MRSA is responsible for NIs in critically ill patients reported to the NNIS system increased from Ͻ 30% in 1989 to up to 40% in 1997. 60 MRSA already accounts for 30% to Ͼ 50% of cases in some European ICUs, particularly in southern Europe and the Mediterranean area. 116, 117 Infection control measures rely on the interruption of cross-transmission by appropriate hand hygiene measures, isolation precautions, and the reduction of selective pressure by inappropriate antibiotic use. 113, [117] [118] [119] Vancomycin-intermediate and glycopeptide-intermediate S aureus have emerged. 120 -123 Routine diskdiffusion for the determination of antibiotic resistance does not correctly identify these strains, which have to be suspected on an epidemiologic basis or in patients with staphylococcal infections and a poor response to despite adequate glycopeptide therapy. 124 The precise mechanism responsible for the emergence of these strains has not been fully elucidated. 125 The vanA, vanB, and vanC genes, which are responsible for glycopeptide-resistance acquisition among enterococci, were not isolated from these strains, suggesting a different mechanism of resistance. Epidemiologic data suggest that the increased use of glycopeptides in hospitalized patients may play a role in this evolution. 120 -122 Infection control measures rely on the strict application of all the guidelines recommended for the prevention and control of MRSA. 126, 127 
VRE
The rate of VRE infection increased from 0.5% in 1989 to 22% in 1997 among ICU patients with NIs reported to the NNIS, and bacteremia due to enterococci may be particularly difficult to treat. 128, 129 Risk factors associated with the acquisition of gentamicin resistance by enterococci in a general hospital reported by Axelrod and Talbot 130 included length of stay, mean duration of antibiotic therapy received, and admission to an ICU. GI colonization with VRE and the use of antimicrobial agents active against anaerobes were found by Edmond et al 131 to be risk factors for the development of VRE bacteremia. This was recently confirmed by Donskey et al 132, who found that antianaerobic agents promoted highdensity colonization with VRE. In an accompanying editorial, Wenzel and Edmond 133 highlighted the importance of these findings, which support the concept of antibiotic pressure (ie, the crude relationship between the extent of antibiotic use and the selection of resistant strains). VRE may be found in the stool samples of as many as 47% of asymptomatic patients after antibiotic administration. 134 
ESBLs
Outbreaks of NIs caused by multiresistant Enterobacteriaceae have been reported. [135] [136] [137] Brun-Buisson et al 112 described an outbreak caused by Klebsiella pneumoniae that successively involved three ICUs in the same hospital. The resistance was plasmid-mediated. In a prospective study on the colonization of critically ill patients with ESBLs over a six-month period, De Champs et al 138 identified prolonged ICU stay as a significant risk factor and reported a decrease in the number of colonized patients after a change in the antibiotic policy.
Other Gram-Negative Pathogens
The proportion of other Gram-negative bacilli, such as P aeruginosa resistant to third-generation cephalosporins or to carbapenems, has remained stable at around 15% in most centers. The NNIS system has reported 35 that the incidence of fluoroquinolone-resistant P aeruginosa has increased from 5% in 1989 to up to 15% in 1997 among ICU patients with NIs. Ventilator-associated pneumonia due to these microorganisms has already been reported 139 in some European centers to be associated with worse outcome.
Candida spp
In the United States, the rate of severe fungal infections increased from 2.0 to 3.8 episodes per 1,000 hospital admissions between 1980 and 1990 in 115 participating hospitals in the NNIS system, with Candida spp responsible for 78% of those episodes. 140 During the same period of time, the incidence of candidemia increased fivefold in medical centers having Ͼ 500 beds and 2.2-fold in those with Ͻ 200 beds. Candida was responsible for 7.2% of bloodstream infections (10.2% in ICUs), preceded by enterococci, S aureus, and CoNS. 141 Epidemiologic data from 1992 to 1997 indicate that fungal infections accounted for 12% of NIs. 35 A 20-fold increase in the rate of candidemia was reported in a single institution where NIs were prospectively surveyed from 1981 through 1990. 142 However, recent data suggest that this incidence may be stable in some other institutions. 143, 144 The emergence of serious infections related to Candida glabrata and Candida krusei, which are mostly resistant to triazoles (fluconazole and itraconazole), was reported [145] [146] [147] [148] by bone-marrow transplant centers and some ICUs, where the proportion of these strains may represent Ͼ 50% of isolates from colonized patients. However, no such evolution has been reported 23, 149, 150 in other institutions where the use of triazole prophylaxis was restricted to high-risk patients. The importance of these findings has to be balanced by the observation that the reduction of infections related to Candida albicans is largely superior to the increase of those related to intrinsically resistant strains of non-albicans Candida spp. 151, 152 Data from a surveillance program, which was designated to monitor the epidemiology of pathogens in 72 medical centers worldwide, indicate that C albicans remained largely predominant in the late 1990s. 153, 154 In fact, 97% of strains from European medical centers were susceptible to fluconazole; 86.5% were highly susceptible (minimum inhibitory concentration needed to kill 50% of isolates [MIC 50 ], Ͻ 8 g/mL), 10.6% were dose-related susceptible (MIC 50 , between 8 and 32 g/mL), and 84% were susceptible to itraconazole (60.6% were highly susceptible [MIC 50 , Ͻ 8g/mL]; and 23.5% were dose-related susceptible [MIC 50 , 8 to 32 g/ mL]). These data confirmed those obtained in US medical centers where 75% of strains were hospitalacquired, including 44% from ICU patients. 154 
Surveillance of NIs
The surveillance of NIs was recognized to be a major component of infection control in the late 1970s. The Study on the Efficacy of Nosocomial Infection Control 18 showed that NI rates decreased on average 32% in hospitals where surveillance programs were implemented, compared with an increase of 18% in other institutions over a 5-year period. The four key elements for successful prevention were the following: the presence of at least one epidemiologist for 1,000 beds; one specialized trained nurse for 250 beds; the existence of a planned surveillance system; and restitution of NI rates. Such programs were rapidly imposed in the United States as important criteria for hospital accreditation. 155 Although less widespread than in the United States, infection control programs also were shown to be effective in Europe. 156, 157 Surveillance includes the following several distinct components: epidemiologic surveillance and intervention; administrative controls for medical equipment, for health-care personnel, and for patients; and engineering controls ( Table 7) . These have to be viewed as tools that have to be appropriately selected to solve specific problems. 15, 158 Epidemiologic surveillance is defined as the continuous collection, tabulation, analysis, and dissemination of all information on the occurrence of NIs in a specified ward and/or hospital. 159 Several concepts have been developed, and the major advantages and disadvantages of specific tools are presented in Table  8 . Total surveillance with the meticulous collection of clinical and microbiological data for each hospitalized patient is labor-intensive, time-consuming, and not always feasible on a practical basis. 60 At the other end of the spectrum, the computerized surveillance of data from the microbiology laboratory alone gives limited information, which may be pertinent to a specific problem. Other types of computerized systems may be extremely helpful and may facilitate the rapid identification and handling of specific problems. For example, we implemented a fully computerized automatic alert system to identify at the time of hospital admission any patient in whom MRSA has been identified previously by the microbiology laboratory either during a previous hospital stay or during ambulatory care. 29 This automatic alert system is now used to detect other resistant organisms and carriers.
In practical terms, a combined approach allows for the optimal use of resources. 158 Continuous monitoring of different infections or microorganisms is mandatory to detect outbreaks that requires both specific and emergency measures. 160 The surveillance of defined infections in particular wards or units may be useful for particular epidemiologic profiles and may help to design targeted programs to reduce the number of NIs. 23, 24, 118, 161 Administrative controls are guidelines that must be checked and executed by HCWs (Table 7) . However, some controls are effective only if appropriate changes are incorporated into routine activities. We experienced a cluster of invasive pulmonary aspergillosis in nonimmunocompromised critically ill patients associated with room air-filter replacement. 162 Such fatal infections could have been prevented by the development and the application of guidelines for this procedure.
Control and Prevention of NIs
Prevention plays a major role in the control of NIs, and consensus conference and expert panels have 100, [163] [164] [165] [166] These guidelines concern three main approaches, which can be schematized as follows. First, methods and techniques are needed to prevent cross-contamination and to control the potential sources of pathogens that could be transmitted from patient to patient or from HCW to patient. These methods and techniques include appropriate protocols for cleansing, disinfecting, and caring for various pieces of equipment and devices. Second, guidelines are needed for the appropriate use of surgical antibiotic prophylaxis or empirical therapy among selected groups of patients. Third, strategies to limit the emergence of resistant microorganisms need to be developed. In addition, specifically targeted measures against various types of NIs also have been proposed.
Isolation Precautions
More than 50% of patients who are admitted to ICUs already have been colonized at the time of admission with the microorganism responsible for subsequent infection; some patients will acquire it from the environment. The CDC 164 has published guidelines on isolation precautions to minimize the risk of transmission of infectious agents from colonized/infected patients to other patients or HCWs. In brief, these guidelines are based on the application of the concepts of standard precautions (Table  9 ). Microorganisms may be transmitted by airborne droplet nuclei, by large-particle droplets, or by direct contact. Additional specific precautions are recommended accordingly (Table 10) .
However, despite the fact that the use of guidelines has become a popular approach to improve the process of care, efforts to implement them in clinical practice often have been unsuccessful. 167 Most requirements regarding infection control measures are unpopular and require restrictive procedures for which compliance is difficult to maintain, and it has been suggested that noncompliance is connected with the yearning of human beings for liberty. 168 This is the case in the particular field of the MRSA pandemic, despite the fact that infection control measures have been proved to be efficacious and cost-effective. 169 It has been shown that noncompliance may be related to several aspects of human behavior, including the false perception of an invisible risk, the underestimation of individual responsibility in the epidemiology of the institution, passive attitudes regarding the increasing complexity of the process of care, and the negative impact of the socioeconomic constraints that are responsible for understaffing. 168 Local factors have to be taken into account to help to incorporate changes in the behavior of both the patients and the HCWs. 168, 170 As discussed in specific sections below, we have observed a strong positive impact in our institution after applying these concepts to the hospital-wide promotion of a bedside hand disinfection technique and to the implementation of an educational program targeted at vascular access care in the medical ICU. 24, 25 CHEST / 120 / 6 / DECEMBER, 2001
Standard Precautions
The key role of HCWs hands in the transmission of pathogens from patient to patient was demonstrated Ͼ 150 years ago by Ignaz Semmelweis. This obstetrician from Vienna was able to dramatically reduce the mortality related to puerperal fever by implementing systematic hand disinfection in chlorinated lime before examining patients. 171 Since then, routine hand washing before and after patient contact remains the most important infection control measure. 172, 173 The endemic transmission of exogenous staphylococci and other potential pathogens by the hands of HCWs is well-documented. 91,94 -97 This phenomenon is of particular concern in the ICU where patient care necessitates frequent contact. Goldmann et al 98 reported the presence of Gram-negative bacilli on the hands of 75% of neonatal ICU personnel. As already mentioned, data have shown that one third to two thirds of the hands of HCWs in ICUs were found to be colonized by Candida spp. 99 We have demonstrated 174 that bacterial contamination of the hands increases linearly with time on ungloved hands during patient care (16 colony-forming units [CFU] per minute; 95% CI, 11 to 25 CFU/min). Higher contamination was documented with direct patient contact such as respiratory care, handling of body fluid secretions, and interruption in the sequence of patient care (ie, the HCW left the patient's bedside to accomplish another task such as answering a telephone and then returned to resume care). We found that the method of hand cleansing before care affected the amount of bacterial contamination; in particular, the absence of hand disinfection before patient care was associated with an increase of 68 CFU (increase, 16 to 119 CFU), independent of the type of care provided and the hospital location. 174 Updated guidelines for hand washing and/or hand disinfection were published by the Healthcare Infection Control Practices Advisory Committee (HICPAC) 175 in 1995 (http://www.cdc.gov/ncidod/ hip/sterile/sterile.htm). However, low-level compliance with hand hygiene has been systematically reported, particularly in ICUs where it does not exceed 40%. 118,176 -178 Several reasons have been suggested for such a low level of compliance, including the lack of priority over other required procedures, insufficient time, inconvenient placement of hand-washing facilities, allergy or intolerance to hand-hygiene solutions, and lack of leadership from senior medical staff. 177,179 -181 We have reported 174 that compliance was inversely proportional to the number of opportunities per hour of patient care. In addition, those HCWs who do wash frequently and vigorously risk skin damage, which, ironically, results in the shedding of more organisms into the environment. 182 Attempts to improve compliance with hand hygiene have been associated with some improvement. 43, 183 Only a few interventions have been associated with a sustained effect. 25,184 -186 The main parameters associated with successful improvement have been extensively discussed elsewhere (http:// infection.thelancet.com), and examples based on published interventions are given herein.
Experience reported 187 with alcohol-based handrubs suggested that hand disinfection reduces hand contamination more than hand washing. In a study published by Doebbeling et al, 43 a hand-disinfection system using an antimicrobial agent (chlorhexidine) reduced the rate of NIs more effectively than one using alcohol and soap. This improvement was essentially explained by a better compliance with handhygiene instructions when chlorhexidine was used. 43 We observed that the promotion of hand disinfection with an alcohol-based hand-rub solution, which was distributed widely as disposable individual pocket bottles as well as placed at the patient bedside, may significantly improve the compliance of ICU staff for 177 Also available online at http://www.cdc.gov/ncidod/ hip/isolat/isolat.htm. Most common examples are listed, but the list is not exhaustive. †See Table 9 . ‡Certain infections require more than one type of precaution. §See reference 201. Pharyngitis, pneumonia, or scarlet fever in infants and young children. ¶GI, respiratory, skin, or wound infections or colonization with multidrug-resistant bacteria considered by the infection control program to be of special clinical and epidemiologic significance. #For all patients in case of C difficile, or diapered or incontinent patients in other cases. whom almost two thirds of their work time theoretically could be required for optimal adherence to infection control guidelines on hand hygiene practice. 188 This was also the case in a French medical ICU 178 where the increase in compliance to hand hygiene measures from 42.4 to 60.9% was essentially attributed to the availability of an alcohol solution for handrubs. However, the effect of this punctual intervention was not sustained, and compliance decreased over a 3-month period from 60.9 to 51.3%. At our institution, the promotion of an elementary bedside hand-disinfection technique by a hospitalwide campaign resulted in a sustained improvement in compliance with hand hygiene from 48 to 66% over 4 years. During the same period, the prevalence of overall NIs and MRSA transmission decreased from 16.9 to 9.9% and from 2.16 to 0.93 episodes per 10,000 patient-days, respectively. Considering the hypothesis that only 25% of the reduction in the infection rates could be attributed to the improved compliance in hand hygiene practice, this intervention might have prevented Ͼ 900 NIs and, thus, was largely cost-effective. 25 Behavioral changes may have played a key role in the success of this intervention, based on a multimodal and multidisciplinary approach including communication and education tools such as "Talking Walls" (widely exhibited cartoon posters, which are available at www.hopisafe.ch), active participation and positive feedback at both the individual and institutional levels, and the systematic involvement of institutional leaders. 185,189 -191 Other requirements for standard precautions are listed in Table 9 . Gloves should be used for any anticipated contact with blood, mucous membranes, nonintact skin, secretions, and moist body substances of all patients. 192 However, gloves may have small and/or inapparent defects or may be torn during use so that hands may become contaminated. [193] [194] [195] [196] Doebbeling et al 197 showed not only that washing gloved hands was ineffective for decontamination but, also, that 5 to 10% of hands were contaminated after glove removal. This explains why the gloves themselves may be potentially responsible for the unrecognized cross-transmission of pathogens if they are not changed between patient contacts and if hands are not scrupulously washed or disinfected before and after degloving. 198, 199 In addition to gloves and gowns, masks must be used to protect mucous membranes of the eyes, nose, and mouth during procedures and patient-care activities that are likely to generate splashes or sprays of blood, body fluid secretions, and excretions. 164 The simultaneous use of goggles or a mask that includes a transparent eyeshade are strongly recommended for the respiratory care of patients receiving mechanical ventilation (eg, mouth care, suction or aspiration in the endotracheal tube, or aerosol therapy).
Transmission-Based Precautions
In addition to standard precautions, transmissionbased precautions include specific measures according to the mode of transmission of the microorganisms. Although all theoretical requirements for an ideal isolation system would be practically unfeasible, appropriate isolation remains the cornerstone of infection control measures to prevent the transmission of microorganisms from and/or to the patients. Recommendations for patient placement, including isolation in special rooms, are included in the requirements for transmission-based precautions (Tables 10 and 11). 164, 170, 200 Source isolation would prevent the transmission of microorganisms from the patient.
Airborne Precaution: In addition to standard precautions, airborne precautions prevent the transmission of microorganisms transmitted by the inhalation of droplet nuclei or contaminated dust particles. Droplet nuclei are Ͻ 5 m in size and can remain suspended in the air for long periods and can travel long distances. This is the case for patients with pulmonary and laryngeal tuberculosis, varicella and disseminated zoster, acute viral hemorrhagic fever, or measles, who should be placed in a private room with negative air pressure in relation to the surrounding area with at least six air changes per hour and with an appropriate discharge of air before it is circulated to other areas in the hospital. 201 The door of the room should be kept closed. An isolation room with an anteroom is sometimes used, however, it is unknown whether the anteroom adds to the effectiveness of the isolation. The main role of the anteroom is to allow air pressure differentials to be maintained at the time of door opening. When an isolation room with an anteroom is used, the two doors should not be opened at the same time. In addition, the efficacy of such engineering controls applied to the air pressure has to be monitored. Inappropriate outward airflow was observed in 38% of 140 respiratory isolation rooms in the state of New York from 1992 to 1998. Multiple factors were identified as being associated with the malfunction of these sophisticated rooms, including an unbalanced ventilation system, a shared anteroom, a turbulent airflow pattern, and automated control system inaccuracies. All the factors were detected by a simple visible smoke test, which should be included in the list of controls in the charge of infection control programs. 202 Specifications for the ventilation of the room, such as negative pressure with external extraction of the contaminated air after adequate filtration for the patients infected or colonized by airbornetransmitted agents. 203 When such isolation rooms are unavailable, the patient should be placed in a private room or placed in a cohort with another patient infected by the same organism. In these situations, however, a consultation with the infection control team is advised. Airborne precautions require respiratory protection for any HCWs or visitors with high-efficiency masks (dust masks) that have been approved by the National Institute for Occupational Safety and Health (N-95 standard). 170, 203 This also has to be applied to the patient during transport and/or movements outside his isolation room.
Droplet Precaution:
In addition to the standard precautions, droplet precautions prevent the transmission of microorganisms transmitted by large particles (ie, those particles Ͼ 5 m in size) containing infecting microorganisms that are produced during coughing, sneezing, and talking, or during invasive procedures such as bronchoscopy and suctioning. They can also be deposited on the mucous membranes of the host's eyes, nose, and mouth. This is the case for Haemophilus influenzae type B, meningococci, multidrug-resistant pneumococci or any other multidrug-resistant organisms in the respiratory tract (eg, MRSA, ESBLs, or Gram-negative bacteria), pharyngeal diphtheria, Mycoplasma pneumoniae, and some viral diseases (Table 10) . However, a close contact of Ͻ 60 cm to 1 m is necessary for transmission to occur since respiratory droplets do not last very long in the air and usually travel short distances. In addition to the standard precautions, a mask is recommended when an HCW is working within 60 cm to 1 m of the patient. Droplet precautions require the patient to be placed in a private room or to be placed in a room with another patient infected by the same organism. Special air handling and ventilation are unnecessary, and the door may remain open. When these measures are not possible, a spatial separation of at least 60 cm to 1 m between the patient and other patients or visitors should be observed.
Contact Precaution:
In addition to standard precautions, contact precautions prevent the transmission of epidemiologically important microorganisms (ie, MRSA, ESBLs, Gram-negative bacteria, VRE, or Clostridium difficile) that can be transmitted by physical direct or indirect contact with the patient or his direct environment. The patient is to be placed in a private room or in a room with another patient infected by the same organism. For any contact with the patient, HCWs should wear gloves and gowns, which should be removed before leaving the room, and this should be followed by systematic hand disinfection measures. Patient-care devices, including stethoscopes and blood-pressure cuffs, should not be used for other patients without rigorous cleansing and disinfection.
Protective isolation measures for immunosuppressed patients such as those who have undergone transplantation or who are deeply neutropenic, have been published. 201, 203, 204 In addition to standard precautions, they include contact precautions as well as the placement of the patient in a private room with filtrated air instilled in positive pressure. 201, 203, 204 Private rooms with specific ventilation specifications probably could improve the efficacy of airborne droplet and contact precautions, but that kind of specification is particularly difficult to obtain in most ICUs. In addition, some authors [205] [206] [207] have pointed out that, apart from the practical difficulties involved in introducing this isolation measure, additional difficulties also may be associated with some psychological stress that has also to be taken into account. [205] [206] [207] However, because aggressive support for organ failure in a critically ill patient must be considered as an absolute priority, isolation precautions often are imposed as secondary management objectives.
Patients who are readmitted to the hospital are at particularly high risk for carrying and transmitting resistant microorganisms that were acquired during a prior hospitalization. Those with suspected infections should be appropriately segregated at the time of hospital admission. When a private room is not available, patients infected or colonized by the same microorganism can share a room. This situation, which is referred to as cohorting, can be safely used provided that the patients are not infected with other potentially transmissible pathogens and that the likelihood of reinfection with the same microorganism is minimal.
Control of Antimicrobial Use
As previously discussed, the use of antimicrobial agents has been shown to be one of the major determinants in the shift toward resistant strains. 166 Accordingly, most experts in infectious diseases and infection control now recommend a strict limitation of antibiotic use. 208, 209 Several strategies targeted at the use of antimicrobial agents have been suggested to control the emergence of resistance. They include the following: an optimal use of antimicrobial agents; strict control, removal, or restriction of the agents; use of antimicrobial agents in combination; and cycling of the available agents. 210 Antimicrobial use can be divided into the following three categories: definite therapy for proven infections; prophylaxis for specific infections; and empirical therapy for suspicion of infection (with the latter representing the large majority of cases). Considering the high mortality and morbidity associated with NIs, most intensivists systematically apply the concept of early empirical broad-spectrum antimicrobial coverage for critically ill patients in whom the development of an NI is suspected. 208 The selection of antimicrobial agents to be prescribed to critically ill patients is crucial. In a surveillance study of 2,000 consecutive ICU patients, Kollef et al 22 evaluated the treatment administered to 655 patients with either community-acquired infections or NIs. Inadequate antimicrobial treatment was prescribed in 45% of patients with NIs that developed following therapy for a community-acquired infection, in 34% of patients with NIs alone, and in 17% of patients with community-acquired infections (p Ͻ 0.0001). The mortality rate of patients receiving inadequate therapy (52%) was significantly higher than that for those receiving adequate treatment (12%) [ 22 These data confirmed previous observations made in both critically ill and neutropenic cancer patients. [211] [212] [213] [214] [215] [216] [217] [218] This conflict of interest is responsible for a vicious circle in which microorganisms could potentially emerge as the true winners and has stimulated the development of new strategies targeted at a better use of antimicrobial agents. 219 Guidelines for the systematic evaluation of fever in critically ill patients have been developed. 220, 221 They facilitate the early recognition of NIs, which must be based on a high index of suspicion. Additional guidelines [222] [223] [224] [225] for the administration of empirical antimicrobial therapy may help in choosing appropriate agents. The implementation of such general recommendations in both surgical and medical ICUs has been reported to reduce costs without adversely affecting patients' outcomes. 36, 45, 226 Methods for an optimal coverage of pathogens that may be potentially resistant to empirical antimicrobial therapy would include the selection of a new class of antimicrobial agents or the routine administration of combined agents from different classes. It should be mentioned that the efficacy of a combination of aminoglycoside with ␤-lactam remains controversial. Based on an in vitro synergetic effect, its clinical utility was demonstrated only for tuberculosis and HIV infections. In addition, most new-generation agents already cover a very broad spectrum. Accordingly, most experts do not systematically recommend such combinations as initial empirical therapy for any suspected infections. 214, 220, [227] [228] [229] [230] [231] Any empirical treatment has to be reevaluated after 48 to 72 h. By taking into account the results of the initial cultures and the clinical evolution, the spectrum can usually be narrowed without compromising patient outcome. This strategy was recently applied to the management of ventilator-associated pneumonia by Fagon et al. 26 They compared noninvasive vs invasive diagnostic techniques as standard management in a series of 413 consecutive patients suspected of developing such a complication. The invasive workup consisted of bronchoscopy with direct examination, and empirical therapy was started if results of testing were positive. . In addition, the former strategy was associated with a significant reduction in the number of antibiotic-free days at day 7 (2.2 vs 5.0, respectively; p Ͻ 0.001) and at day 28 (7.5 vs 11.5, respectively; p Ͻ 0.001). Furthermore, the mortality rate was markedly reduced at day 14 (26% vs 16%, respectively; p ϭ 0.022). This invasive diagnostic strategy may become the standard of care for diagnosing ventilator-associated pneumonia and should be considered as part of an antibiotic control strategy in the ICU. 232 This may also contribute to limiting the selective pressure of antimicrobial agents on ward microorganisms.
The inappropriate use of antibiotics, related to either too generous or too restrictive use, has stimulated the application of computerized antimicrobial guidelines. Automatic stop orders after 72 h of empirical use have been proposed, but the risk of an inadequate interruption of treatment is worrying. 166 More sophisticated algorithms have been applied. 233, 234 The impact of a computerized decisionsupport program linked to computer-based patient records designed to assist physicians in the use of antimicrobial agents was evaluated by Evans et al 226 over a 12-month period in a 12-bed ICU. Compared with the preceding 2-year period, there was a marked reduction in antibiotic prescriptions (67% vs 73%, respectively; p Ͻ 0.03), in orders for drugs to which the patient had reported an allergy (6.4% vs 13%, respectively; p Ͻ 0.01), in excess drug dosages (16% vs 36%, respectively, p Ͻ 0.01), and in antibiotic-susceptibility mismatching (2.2% vs 18%, respectively; p Ͻ 0.01). Moreover, compared with those who did not receive the proposed regimens and those in the preintervention cohort, patients who always received the recommended regimens had a significant reduction in the cost of antibiotics (adjusted means, $102 vs $427 and $340, respectively; p Ͻ 0.001), in total hospital costs (adjusted means, $26,315 vs $46,865 and $35,283, respectively; p Ͻ 0.001), in the length of ICU stay (adjusted means, 2.7 vs 8.3 and 4.9 days, respectively; p Ͻ 0.001), and length of hospital stay (adjusted means, 10.0 vs 16.7 and 12.9 days, respectively; p Ͻ 0.001). In addition to this reduction in costs and improvement of the quality of patient care, these data also suggested that with computerized algorithms, fewer patients are exposed to lower amounts of antibiotics.
The scheduled change of antibiotic classes, also called antimicrobial agent cycling, has been one of the strategies advocated to limit the trend of increasing antimicrobial resistance among nosocomial pathogens. 210 The use of postoperative antibiotics in addition to the perioperative prophylaxis was high, however, in both periods (45% vs 43% of patients, respectively; p ϭ 0.605), and no impact was shown on mortality rates. Nonetheless, these preliminary data are provocative and suggest that such a strategy could minimize the emergence of resistant microorganisms by reducing the selection pressure for bacteria to develop resistance to a specific antibiotic. 238, 239 Gruson et al 240 reported a positive impact on the incidence of ventilator-associated pneumonia due to resistant Gram-negative bacteria over 4 years after the implementation of a strategy combining a rotation and a restriction of the use of antibiotics. The schedule for antibiotic therapy consisted of monthly rotations of the agents (ie, four different ␤-lactams combined with four different aminoglycosides) for the empirical treatment of pneumonia with a succession of cycles of 4-month periods over 2 years after its implementation. Gruson et al 240 observed a decrease from 231 patients with ventilatorassociated pneumonia in the prestudy period to 161 patients in the period following the study (p Ͻ 0.01). The total number of potentially resistant Gram-negative bacilli responsible for pneumonia decreased from 140 to 79, respectively. If such a strategy could be validated, this may become a highly cost-effective measure. 241 However, these recommendations cannot replace a good knowledge of the local epidemiology and of the resistance profile of the prevailing in-hospital and out-of-hospital pathogens. A multidisciplinary approach, including the microbiology laboratory and experts in infectious disease and infection control, may be required for some difficult cases.
Selective Digestive Decontamination
Colonization is a prerequisite for the development of NIs that frequently arises from the endogenous flora in the oropharyngeal and GI tracts. Antimicrobial prophylaxis targeted at the elimination of these reservoirs has been the subject of very active clinical research during the past 2 decades. 242 The aim of this elegant concept, called selective digestive decontamination (SDD), is to prevent the overgrowth of potentially pathogenic Gram-negative aerobic bacilli and yeasts by using oral, nonabsorbable antibiotics that preserve the endogenous anaerobic flora. 243, 244 In addition to its potential benefit in preventing ICU-acquired infections, SDD was initially thought to contribute to the reduction of endotoxemia from the bowel flora, which may play a role in the pathophysiology of multiple organ failure. 245, 246 After the initial enthusiasm related to positive results in reducing the rates of ventilator-associated pneumonia, randomized controlled studies [247] [248] [249] [250] [251] showed that SDD was effective in selected groups of patients only. Meta-analysis showed conflicting results, possibly due to the effect of early-onset infections, which were not uniformly taken into account or treated in some studies. [251] [252] [253] [254] It was later demonstrated that SDD is only efficient after several days and that its effect can only be considered in patients with late-onset NIs, against which SDD is very effective. [255] [256] [257] [258] Nonetheless, many regimens did include vancomycin or aminoglycoside, and the emergence of resistant microorganisms possibly related to the introduction of SDD was observed in several centers. 259 -261 This selective pressure on the epidemiology of resistance definitely precludes the systematic use of SDD for critically ill patients. However, controlled studies confirmed that it may still have a place in carefully selected groups of high-risk patients in whom its efficacy and cost-effectiveness have been established 251, [262] [263] [264] [265] (Table 12) .
Infection Site and Specific Preventive Measures

Prevention of Ventilator-Associated Pneumonia
Research for effective measures to prevent ventilator-associated pneumonia have been recently reviewed elsewhere 21,266 -268 and is only briefly summarized below.
A large proportion of cases of ventilator-associated pneumonia are related to the continuous aspiration of contaminated oropharyngeal secretions and/or possibly to gastric content. 247, 269, 270 The simplest measure with which to decrease the aspiration of gastric contents in mechanically ventilated patients is to place them in a semirecumbent position (ie, a 45°a ngle). 271 Several randomized studies 272 have found that sucralfate, which does not lower gastric pH, is associated with lower rates of ventilator-associated pneumonia than histamine H2-receptor antagonists, but some data 273 suggest that it may be less efficient in stress ulcer prophylaxis, and this field continues to be controversial. 274 As mentioned previously, SDD is effective in subsets of mechanically ventilated patients. The continuous subglottic aspiration of oropharyngeal secretions over the tracheal cuff is an original concept first developed by Vallè s et al. 275 In a series of 190 mechanically ventilated patients, these authors observed a marked reduction in the incidence-density of nosocomial pneumonia from 39.6 episodes per 1,000 ventilator-days in the control group to 19.9 episodes per 1,000 ventilator-days in patients receiving continuous aspiration. These data have been confirmed by Kollef et al 276 in patients after cardiac surgery.
Noninvasive ventilation was shown to significantly reduce the risk of nosocomial pneumonia. 277, 278 Antonelli et al 279 reported that nosocomial pneumonia or sinusitis occurred in 1 of 32 critically ill patients (3.1%) who received ventilation with noninvasive techniques compared to 10 of 32 patients (32%) who received mechanical ventilation over a 12-month period (p ϭ 0.003). Moreover, observations by Nourdine et al 280 in a 20-bed multidisciplinary ICU over a 27-month period suggested that noninvasive ventilation also may have a positive impact on other NIs. The incidence-density of lower respiratory tract, urinary tract, and bloodstream infections was 14.2 episodes per 1,000 patient-days in 129 patients who had undergone successful noninvasive ventilation, compared with 30.3 episodes per 1,000 patient-days in those patients (607 patients) who required mechanical ventilation. 280 This was also probably related not only to less continuous sedation but also to the use of fewer invasive devices such as central venous access and urinary catheterization.
Nosocomial Sinusitis
Although frequently related to pathogens that are endemic in the hospital, including anaerobes, nosocomial sinusitis is not included in the published data from the NNIS system and is only rarely reported in studies 281, 282 on the epidemiology of NIs in critically ill patients. Cumulative incidence rates between 38.5% and 100% have been reported from prospective observational studies [283] [284] [285] [286] [287] [288] [289] in critically ill patients, and it was suggested that these infections may be responsible for a large proportion of sepsis without other documented foci of infection. However, nonspecific symptoms, especially in critically ill, sedated patients in whom pain and purulent discharge may be unrecognized, as well as the absence of uniform criteria may explain this wide range. More restrictive criteria combining the presence of both purulent secretions and radiologic involvement lead to lower estimates of the incidence of nosocomial sinusitis, which is reported as ranging between 5% and 35%. 282,289 -293 In the early 1970s, retrospective studies 294 strongly suggested that they may be ventilator-associated. Their pathophysiology, elucidated in the 1980s, includes impaired drainage of the sinus cavities in the supine position, slowed venous drainage due to positive-pressure ventilation, and obstructive devices such as nasogastric or nasotracheal tubes. 283, 284, 286 The increased risk of infection due to the presence of a nasal device was confirmed in several trials. 287, 288, 290, 291, 295 In a prospective observational cohort study of 366 patients in two medical ICUs over 1 year, the incidence of nosocomial sinusitis, which was defined as radiographic abnormalities in one or both maxillary sinuses with recovery of microorganisms from cultures obtained by transnasal aspiration, was 7.7% with an incidence rate of 12 cases per 1,000 patientdays (95% CI, 8.3 to 17.3). 291 These rates were 15.7 cases per 1,000 patient-days (95% CI, 10.8 to 22.9) for patients with a nasoenteric tube, whether they received mechanical ventilation or not, and 1.6 cases per 1,000 patient-days (95% CI, 0.3 to 9.1) for those patients without a nasal device. In patients who were receiving mechanical ventilation through orotracheal tubes, the incidence was 19.8 episodes per 1,000 nasoenteric tube-days (95% CI, 13.6 to 28.8). Risk factors identified by multiple logistic regression analysis were as follows: nasal colonization with enteric Gram-negative bacilli (OR, 6.4; 95% CI, 2.2 to 18.8; p ϭ 0,0007); feeding via nasoenteric tube (OR, 14.1; 95% CI, 1.7 to 118; p ϭ 0.015); sedative use (OR, 15.9; 95% CI, 1.9 to 134; p ϭ 0.011); and Glasgow coma scale of Ͻ 8 (OR, 9.1; 95% CI, 3.0 to 27.3; p ϭ 0.0001).
In 1994, Rouby et al 290 evaluated 162 consecutive patients who had received ventilation for Ͼ 1 week, with paranasal CT scans performed within 48 h of hospital admission and 7 days later. The patients were stratified according to the initial radiologic aspect of their maxillary sinuses (normal, 40 patients; mucosal thickening, 26 patients; and radiologic sinusitis defined as the presence of either an air fluid level or total opacification, 96 patients). The patients without sinusitis were randomized either to nasotracheal or orotracheal intubation, and they underwent further imaging studies 7 days later. Radiologic sinusitis developed in 95% of patients with a nasal tube compared to 22.5% of those with an oral tube (p Ͻ 0.001). After 7 days, 46% of the patients with mucosal thickening developed radiologic sinusitis and 12% normalized. In the group of patients with initial radiologic sinusitis, a stepwise logistic regression analysis identified nasotracheal tube (p Ͻ 0.001), nasal gastric tube (p Ͻ 0.05), duration of endotracheal intubation (p Ͻ 0.01), and duration of gastric tube placement (p Ͻ 0.05) to be independent risk factors. The sinusitis could be microbiologically confirmed by a transnasal puncture in only 51 of 133 patients (38%) who had a radiologic involvement. Despite the fact that Ͼ 80% of patients had radiologic involvement of the ethmoid and sphenoid sinuses, the drainage of the maxillary sinuses with only lavages twice daily (ie, 5 mL saline solution with 50 mg amikacin) without systemic antibiotic therapy was associated with an improvement of sepsis in 49% of patients, 67% of whom had microbiologically documented sinusitis. Among patients with initial radiologic sinusitis, ventilator-associated pneumonia developed in 67% in whom sinusitis was microbiologically documented after 7 days, compared to 43% in the rest of the group (p Ͻ 0.02).
These elegant studies confirmed that foreign devices in the nose represent a major risk factor for the development of nosocomial sinusitis, which itself is a risk factor for the development of pneumonia. More importantly, it also suggests that although a definite diagnostic regimen should include a transnasal punc-ture, drainage and lavage for Ͼ 15 days without systemic antibiotic therapy may also be useful in the management of ventilated patients with sepsis of unknown origin in the presence of radiologically documented sinusitis.
In a study from France, Holzapfel et al 289 evaluated the impact of a systematic search and treatment of maxillary sinusitis in 399 patients who had received mechanical ventilation through a nasotracheal tube on the occurrence of ventilator-associated pneumonia. In the intervention group, sinusitis, defined as a temperature of Ն 38°C with radiologic signs evident on a CT scan in the presence of purulent transnasal aspirate of the involved sinus, was diagnosed in 80 of 199 patients and was treated by lavage and systemic antibiotic therapy. In the control group, no patient was treated for sinusitis. Ventilator-associated pneumonia then was observed in 37 patients (34%) in the study group and in 51 patients (47%) in the control group (RR, 0.61; 95% CI, 0.40 to 0.92; p ϭ 0.02). Overall, the 60-day mortality rate was further estimated at 36% in the study group and 46% in the control group (RR, 0.71; 95% CI, 0.52 to 0.97; p ϭ 0.03).
In summary, nosocomial sinusitis is probably underestimated in critically ill patients who are receiving mechanical ventilation, in whom it may be viewed as a direct consequence of impaired drainage capability of the sinus cavities due to devices placed in the nose. 281 This represents a significant risk factor for the development of further nosocomial pneumonia. Its prevention would include the avoidance of nasotracheal intubation and the systematic use of the orotracheal route, which is the current practice in many ICUs. Scrupulous oral hygiene for patients receiving mechanical ventilation is mandatory. Nasotracheal feeding tubes should theoretically also be avoided, but this is practically difficult in nonsedated patients.
Bloodstream Infections and Specific Preventive Measures
A large proportion of catheter-related infections are preventable through careful control of the factors associated with their colonization by microorganisms. 24, 60, 73, 296 For example, the insertion site of the catheter was demonstrated to be an important risk factor and is potentially easily influenced by clinical practice. Growing evidence 297, 298 has suggested repeatedly that central lines inserted into the jugular site are more likely to be colonized than those lines inserted by the subclavian route. This could be related to factors favoring skin colonization such as proximity of oropharyngeal secretions, higher skin temperature, and difficulties in immobilizing the catheter and maintaining an optimal dressing, particularly in men. 299 Although infection rates for CVCs inserted through the femoral vein have not been reported to be higher since the beginning of the 1990s, despite potentially less severe complications related to their insertion, they may be associated with a higher rate of deep venous thrombosis. At present, insufficient data are available to recommend their systematic use. 300 The use of a tunneled short-term CVC has been reported to be associated with a decreasing rate of device-related infection, and a meta-analysis 301 of randomized controlled trials concluded that it may be the case only for those CVCs inserted into the jugular site. An accompanying editorial highlighted the fact that blood drawn through the catheter was not allowed in the largest study included in the meta-analysis, a factor that might have contributed to the low reported rate of infection. 302, 303 The same comment has to be made about a more recent large randomized controlled study 304 in which the authors reported that catheter-related sepsis occurred in 5 of 168 patients (3.0%) who had received femoral tunneled CVCs compared with 15 of 168 patients (8.9%) who had received nontunneled CVCs (RR, 0.25; 95% CI, 0.09 to 0.72). The proportion of CVCs used for drawing blood is generally not specified in most studies, and many institutions favor arterial lines for this purpose.
Prospective, randomized clinical studies 297, [305] [306] [307] have shown that the use of CVCs impregnated on their external surface with chlorhexidine-silver-sulfadiazine were associated with a marked reduction of microbiologically documented, catheter-related infections. A meta-analysis 308 of 2,611 catheters from 12 studies found that these catheters were associated with a reduction of colonization (OR, 0.44; 95% CI, 0.36 to 0.54; p Ͻ 0.001) and catheter-related bloodstream infection rates (OR, 0.56; 95% CI, 0.37 to 0.84; p ϭ 0.05). A cost-effectiveness analysis based on these results suggested that a decreased incidence of catheter-related bloodstream infections of 3.4 to 1.2% corresponded to a cost savings of $68 to $391 per catheter used. 309 Catheters impregnated with minocycline and rifampin on both the external surface and the intraluminal face also were associated with a reduction of microbiologically documented, catheter-related infections. 310 These new materials have been compared in a multicenter study. 298 The minocycline/rifampin-impregnated catheter was reported to be associated with significantly lower levels of colonization (RR, 0.35; 95% CI, 0.24 to 0.55) and catheter-related bloodstream infection (RR, 0.08; 95% CI, 0.01 to 0.63). The authors argue that this difference may be due, in part, to the lack of antibacterial activity on the intraluminal surface. This is consistent with the results of another study 311 in which the silver/chlorhexidine catheters were not associated with a reduction of the catheter-related infection rates. Recent data on the determination of colonization and residual antimicrobial ex vivo activity after removal of 113 CVCs that were no longer required, strongly favors this hypothesis. 312 It has been suggested that the potential cost-benefit could be sufficiently high to favor the use of these secondgeneration catheters in ICUs. 298, 313 However, the duration of catheterization may have played a role. Impregnated catheters failed to prevent catheterrelated infections in only one study, which included neutropenic cancer patients with a mean duration of catheterization of 20 days 311 compared to 6, 298 7, 305 and 8.3 310 days in other reports. This may be confirmed by our data from a meta-analysis 314 of 20 studies including 3,981 catheters that showed that the maximum benefit of coating was achieved during the first week of catheterization (relative benefit, 0.35; 95% CI, 0.18 to 0.67) and that no additional benefit was apparent beyond 2 weeks of use. Despite these impressive results, these devices may be potentially associated with the emergence of resistance, and their eventual place in the care of patients remains to be determined. 139, 315 Other preventive approaches, based on the implementation of locally adapted practice guidelines to take into account careful indication and choice of the type of vascular access, rigorous insertion practice, and optimal catheter care with regular surveillance programs, have been developed (Table 13) . 296, 316, 317 We recently reported 24 the impact of a global strategy targeted at the reduction of catheter-related infections in 3,154 critically ill patients who had been consecutively admitted to our medical ICU. The results revealed a decrease in the incidence of nosocomial bloodstream infections by 67% (RR, 0.33; 95% CI, 0.20 to 0.56; p Ͻ 0.001), corresponding to a decrease from 6.6 to 2.3 episodes per 1,000 CVC-days and a 64% decrease in exit-site catheter infections (RR, 0.36; 95% CI, 0.20 to 0.63; p Ͻ 0.001). Importantly, the overall incidence of ICU-acquired infections was reduced by 35% (RR, 0.65; 95% CI, 0.54 to 0.78; p Ͻ 0.001). Our prevention strategy may have prevented Ͼ 75 NIs during the 8 months of the intervention, including at least 30 primary bloodstream and 25 vascular-access infections. Using conservative estimates of the attributable costs associated with the latter two types of infections when transferred to the Swiss health-care setting, the program was largely beneficial for the patient and the hospital. 73, 318 The prevention of those infections would amount, at least, to the annual salary of three full-time infection-control nurses.
Sherertz et al 319 recently reported that an educational program for physicians in training also can decrease the risk of catheter-related infection. A 1-day course on infection control practice and on procedures targeted at vascular access insertion was shown to reduce the rate of catheter-related infections by 27%, from 3.3 to 2.4 per 1,000 CVC-days. 319 Importantly, the impact obtained from the reduction of NIs in these two studies 308, 309 was largely superior to that expected with the use of antimicrobial/antisepsis-coated catheters. Behavioral changes may have played a key role in the success of these interventions.
UTIs
Nosocomial UTIs are almost exclusively related to urinary catheters or invasive urinary tract procedures. Sixty-nine percent of the 181,993 patients hospitalized in 112 medical ICUs in NNIS hospitals from 1992 through 1997 had urinary catheters. 35 This proportion ranged from 32% in pediatric ICUs, to 44% in coronary-care units, and to Ͼ 80% in cardiothoracic and trauma ICUs. 48, 60 It was reported 320 that the incidence of bacteriuria is approximately 5% per day of catheterization, possibly explaining why UTIs are reported to account for between 25% and 50% of all NIs. 42, 320, 321 The incidence-densities of UTIs vary from 3.3, to 7.6, to 10.1 episodes per 1,000 urinary catheter-days, respectively, in cardiothoracic, medical, and burn ICUs 60 (Table 2) . Most episodes are asymptomatic, and the associated low morbidity and mortality justifies that the surveillance for and treatment of asymptomatic nosocomial bacteriuria is not recommended for most ICU patients. 321, 322 However, this point needs to be reviewed in the case of immunosuppressed patients.
The pathophysiology of UTI is characterized by a rapid colonization by microorganisms from the colonic flora along the urinary catheter. A quantitative culture of Ն 10 5 CFU/mL is the threshold admitted for a diagnosis of catheter-associated bacteriuria. [323] [324] [325] [326] Risk factors include the duration of catheterization, the absence of systemic antibiotic treatment, diabetes mellitus, and renal failure. 320,326 -328 Data from the 1980s 79, 329, 330 has suggested that UTIs can prolong the length of a hospital stay by 1 to 3 days with a threefold probability of death during hospitalization. An attributable mortality rate of 12.7% was reported 331 for urinary tract-related bacteremia in a study of bacteremia. However, this was not based on a strict case-control approach, and it should be viewed as an estimate and should be interpreted with caution. In a recent pooled analysis of 30 studies published between 1966 and 1998, Saint 332 determined that bacteriuria would occur in 26% of hospitalized patients (95% CI, 23 to 29%) who have an indwelling catheter for 2 to 10 days. Among patients with bacteriuria, symptoms of UTI and bacteremia will develop in 24% of patients (95% CI, 16 to 32%) and 3.6% of patients (3.4 to 3.8%), respectively. The author further estimated that the additional costs of a case of UTI-related bacteremia would include the costs of microbiological analysis, antimicrobial therapy, and at least 2 extra days in the ward and 1 extra day in the ICU. However, the exact rate of UTI-related bacteremia remains a controversial issue, and Tambyah and Maki 333 recently reported that secondary bacteremia developed in only 1 of 235 episodes (0.4%) of catheter-associated bacteriuria that complicated the course of 1,497 newly catheterized patients in a university hospital.
The prevention of catheter-related UTI has been a field of active clinical research since the demonstration 30 years ago that a closed drainage system significantly reduces the infection rate. 322, 327, 334, 335 As for any other device used in the management of critically ill patients, and is an apparently trivial concern compared to more sophisticated strategies, catheterization should be avoided when not strictly required and should be terminated as soon as possible. 336, 337 As compared with urethral catheters, suprapubic catheters have been demonstrated to be associated with a lower risk of UTI and a higher rate of satisfaction. They may also reduce the risk of local genitourinary complications such as prostatitis, epididymitis, or urethral stricture. 338 -344 The use of an external condom catheter has shown contradictory results. [345] [346] [347] [348] Although these alternative devices are not commonly used, further large randomized, controlled studies are needed in critically ill patients to define the place of these devices in the prevention of UTIs. 337, 349 Bladder irrigation with disinfectants and/or antibiotics, or their instillation in the drainage bag, is of limited benefit in the presence of closed systems, and the potential impact on the epidemiology of resistance currently argues against the recommendation of their use. 337,350 -352 Despite strong arguments in favor of the role of urethral meatus colonization in the pathophysiology, the results of two randomized controlled studies 326, 353 failed to demonstrate any benefit from rigorous cleansing, even when combined with topical antibiotic applications. Prophylaxis with systemic antibiotic therapy significantly reduces the incidence of catheter-associated UTIs but is of limited benefit for a catheterization time of Ͻ 3 days, and bacteriuria will develop in almost all patients after 2 weeks. In addition, the potential for adverse drug reactions and the selective pressure on the emergence of resistant strains have contributed to the lack of a routine recommendation for such prophylactic measures, with the exception of patients requiring specific urologic procedures. 322, 337, 354, 355 As for vascular access-related infections, the use of antiseptic-coated and/or antibiotic-coated catheters was demonstrated to be effective in the prevention of catheter-associated UTIs. 356, 357 A meta-analysis 358 that included a total of 2,355 patients suggested that silver-oxide catheters, which are no longer available in the United States, were not associated with the significant reduction of UTIs (OR, 0.79; 95% CI, 0.57 to 1.10) that was, however, shown for silver alloy catheters (OR, 0.24; 95% CI, 0.11 to 0.52). However, major heterogeneity was observed between the eight randomized controlled studies retrieved from the 117 reports included in this analysis. 358 A recent cost-effectiveness model 359 suggested that, compared to standard catheters, this type of device may be associated with a modest cost saving of $4 in patients requiring catheterization for 2 to 10 days. Further studies are needed to assess whether these new devices should be used routinely or whether they should be considered for high-risk patients only. 337, 360 
SSIs
The prevention of SSIs relies on correct surgical technique, modification of host risk factors, and adequate antimicrobial prophylaxis. 361 Trivial factors, which may be controlled by very simple measures, have been shown to significantly impact on SSI rates. Mild perioperative hypothermia is common in most patients undergoing surgery, and this may increase patients' susceptibility to SSIs by causing vasoconstriction and impaired immunity. 362, 363 In an elegant prospective study, Kurz et al 364 demonstrated that the active maintenance of normothermia (mean [Ϯ SD] temperature, 36.6 Ϯ 0.5°C vs 34.7 Ϯ 0.6°C; p Ͻ 0.001) reduced the SSI rate after colorectal surgery from 19 to 6% (6 of 104 patients compared to 18 of 96 patients, respectively; p ϭ 0.009). An inverse relationship between subcutaneous tissue oxygen tension and SSI rates has been suggested. 365 Greif et al 366 recently reported the impact of 80% supplemental oxygen during surgery and for 2 h after surgery in a cohort of 500 patients who had undergone elective colorectal resection. An SSI occurred in 13 of 250 patients (5.2%) who received this regimen compared with 28 of the 250 patients (11.2%) who received 30% supplemental oxygen only (absolute difference, 6.0%; 95% CI, 1.2 to 10.8%; p ϭ 0.01). 366 The prophylactic administration of antibiotics can decrease postoperative morbidity, can shorten hospitalization, and can reduce the overall costs attributable to infections. 367, 368 However, prophylactic therapy should be used as little as possible with a spectrum of activity as narrow as possible to avoid the development of bacterial resistance. Antibiotic prophylaxis is clearly indicated for contaminated or clean-contaminated surgery and for clean operations such as those involved in the insertion of prosthetic devices, which are associated with a low risk of infection and high morbidity. 369 Extension to other categories of clean procedures should be limited to patients with additional risk factors. Cefazolin (or cefoxitin when anaerobic coverage is necessary) remains the mainstay of prophylactic therapy. The selection of an alternate agent should be based on specific contraindications, local infection control surveillance data, and the results of clinical trials. To maximize its effectiveness, IV perioperative prophylaxis should be given within 30 to 60 min before the time of surgical incision (ie, at the induction of anesthesia in most cases). 370 -372 Precise guidelines for specific surgical procedures have been published periodically, but many reports continue to describe inappropriate drug use such as invalid indications or the use of broad-spectrum drugs. 233, 373 Improving compliance with the guidelines must become one of the priority targets of infection control programs, which should ensure that they are adapted to local epidemiology or work conditions. One of the most beneficial measures in this setting is certainly the surveillance of SSIs. 233, 374, 375 Periodic feedback to the surgical teams is the cornerstone of SSI prevention. 233, 376 Other NIs Hospital-acquired diarrhea may be of infectious or noninfectious origin. Common noninfectious causes include medication-induced changes in the colonic flora without acquisition of an enteric pathogen or changes secondary to enteral nutrition. [377] [378] [379] [380] Infectious causes may be due to enteric pathogens of both endogenous and exogenous origin and often occur in outbreak situations. Bacteria, fungi, and viruses have been described as causes, but in a large majority of adults infections are due to C difficile. 378, 381, 382 First described in 1935, it was only identified as the etiologic agent of pseudomembranous enterocolitis at the end of the 1970s. This bacteria may be a resident of the human colon, where it does not cause disease until toxins are produced. 383 The spectrum of disease includes asymptomatic carriage to mild watery diarrhea, severe diarrhea, and life-threatening pseudomembranous enterocolitis. 384 C difficile-related diarrhea is usually associated with the prior administration of antibiotics, of which clindamycin, combinations including ␤-lactamase inhibitors, and third-generation cephalosporins appear to confer the highest risk. 378, 380, 385 Its acquisition is common in hospitalized patients, and cross-transmission has been related to transient carriage on the hands of HCWs and contamination of the environment or to medical equipment such as electronic rectal thermometers. 386 -388 In addition, diarrhea may contribute to the spread of other resistant organisms such as VRE. In the presence of diarrhea, the diagnosis requires positive results for one of the following tests: pseudomembranes revealed by endoscopy; positive stool enzyme immunoassay for toxin A or B; or positive stool cultures. Diarrhea is treated with oral metronidazole, and colitis is treated with IV metronidazole. Oral vancomycin must be restricted to infrequent circumstances, considering its potential impact on the emergence of VRE. 119, 389 The testing of asymptomatic patients, including those who are asymptomatic after treatment, in an attempt to eradicate symptomless carriage is not recommended but may be debated in an outbreak situation. 377, 384 Infection control measures are necessary to prevent the spread of this spore-forming organism, which is already capable of surviving in the hospital environment for prolonged periods. Measures have focused on improved hand hygiene compliance, barrier precautions, reduction of environmental contamination by cleansing and disinfection, and antibiotic restriction policies. 164, 387 Restricting clindamycin therapy was particularly successful in terminating outbreaks of C difficile diarrhea associated with its use, but since almost all antimicrobial agents have been associated with C difficile infection, overall restriction is recommended. 390, 391 
Prevention of Infection in HCWs
The protection of HCWs from the acquisition as well the transmission of infectious agents and the management of postexposure care are important tasks for hospital infection control programs. Precise guidelines have been published by the CDC Hospital Infection Control Practice Advisory Committee and are available at http://www.cdc.gov/ncidod/hip/ guide/infectcont98.htm. 392 The prevention strategies included in these recommendations include immunization for vaccine-preventable diseases, isolation precautions to prevent exposures to infectious agents, management of HCWs who have been exposed to infected patients, including postexposure prophylaxis, and work restrictions for exposed or infected HCWs.
Hospital policies should be edited for the medical personnel, including those not directly involved in patient care such as laboratory technicians, laundry workers, or transport teams. HCWs should be evaluated to assess their risk of acquiring or transmitting infection in the hospital to patients or other HCWs in a systematic pre-employment examination and eventual periodic examination. Immunization status must be checked and updated for tetanus, measles, rubella, mumps, pertussis, and hepatitis B. Some institutions also recommend serologic testing for varicella zoster virus and offer an attenuated vaccine for susceptible HCWs. Some authors have recommended hepatitis A vaccination for HCWs who are involved in pediatric care. Mantoux testing with appropriate follow-up should be systematic if the test results are positive. Outbreaks of influenza have been related to transmission by HCWs, and systematic yearly immunization should be encouraged. This not only reduces the influenza attack rates among patients, leading to substantial mortality rate among some subsets of patients, but may also reduce flu-like diseases and absences from work. [393] [394] [395] [396] The prevention of transmission of any pathogen to HCWs, as to other patients and/or visitors, is based on the strict application of the guidelines for standard precautions and transmission-based precautions that already have been discussed (Table 9 and 10). 164 All HCWs, not only doctors, nurses, and nursing assistants, but also respiratory and mobilization therapists, phlebotomists, radiology technicians, laboratory technicians, and transporters should receive initial training with refresher courses in the appropriate methods and techniques to avoid percutaneous, damaged skin, or mucus membrane contact with blood or other body fluid secretions.
Postexposure management of the HCWs is indicated for significant exposure to HIV, hepatitis B, Neisseria meningitidis, Mycobacterium tuberculosis, and varicella zoster virus. Detailed protocols should be immediately available 24 h per day through the emergency department or through a specialized infectious disease infection control consultant, and every exposure has to be the subject of an individualized evaluation to offer the best available management strategy. 397, 398 
Conclusion
The importance of nosocomial transmission in the ICU cannot be overemphasized. More than one third of NIs are acquired in ICUs, accounting for a crude incidence of 15 to 40% of hospital admissions, depending on the type of unit. 158 Since more severely ill patients have higher risks for both acquiring NIs and for mortality, assessment of the mortality attributable to NIs in ICU patients is not straightforward. Nevertheless, NIs are definitely associated with substantial excess length of stay and additional hospital costs. 16, 22, 73, 77 Although patients' intrinsic risk factors for developing infections are difficult to modify, the risk of transmission of microorganisms can and should be reduced to a minimum. An improved knowledge of the pathophysiology will help to understand the concepts of infection control. In this review, we have emphasized the transmission risks, which are particularly high in critically ill patients, and have discussed the scientific background of precaution guidelines, which have been summarized in order to be appropriately implemented in the ICU.
